Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Pancreatitis

  Free Subscription


Articles published in Br J Surg

Retrieve available abstracts of 88 articles:
HTML format



Single Articles


    March 2024
  1. THEIJSE RT, Stoop TF, Janssen QP, Prakash LR, et al
    Impact of a non-therapeutic laparotomy in patients with locally advanced pancreatic cancer treated with induction (m)FOLFIRINOX: Trans-Atlantic Pancreatic Surgery (TAPS) Consortium study.
    Br J Surg. 2024;111:znae033.
    PubMed     Abstract available


  2. IMAMURA T, Ashida R, Urakami K, Ohshima K, et al
    Comprehensive sequencing of circulating tumour DNA in resectable pancreatic cancer.
    Br J Surg. 2024;111:znae059.
    PubMed    


    January 2024
  3. VAN BEEK DJ, Van Den Heede K, Rinkes IB, Norlen O, et al
    Surgery for advanced pancreatic neuroendocrine neoplasms: recommendations based on a consensus meeting of the European Society of Endocrine Surgeons (ESES).
    Br J Surg. 2024;111:znae017.
    PubMed    


  4. LARSSON P, Soreide K
    Surgery for oligometastatic pancreatic cancer: next frontier?
    Br J Surg. 2024;111:znad419.
    PubMed    


  5. OMIYA K, Maekawa A, Oba A, Inoue Y, et al
    A proposal of ABCD metastasectomy criteria for synchronous/metachronous metastatic pancreatic cancer in the era of multidisciplinary treatment.
    Br J Surg. 2024;111:znad417.
    PubMed    


    December 2023
  6. ONNEKINK AM, Michiels N, Klatte DCF, Oldenburg L, et al
    Surgical outcomes after pancreatic surgery in patients with a germline CDKN2A/p16 pathogenic variant under surveillance.
    Br J Surg. 2023 Dec 29:znad430. doi: 10.1093.
    PubMed    


  7. HALL LA, Powell-Brett S, Halle-Smith J, Ward L, et al
    Pancreatic exocrine insufficiency after non-pancreatic upper gastrointestinal surgery: meta-analysis.
    Br J Surg. 2023 Dec 8:znad369. doi: 10.1093.
    PubMed     Abstract available


    November 2023
  8. KIRKEGARD J, Ladekarl M, Johannsen IR, Mortensen F, et al
    Effect of adjuvant chemotherapy after pancreatectomy in patients with node-negative pancreatic cancer: target trial emulation.
    Br J Surg. 2023 Nov 25:znad398. doi: 10.1093.
    PubMed     Abstract available


  9. SCHLAPFER M, Schadde E, Braun J, Soll C, et al
    Effect of volatile versus total intravenous anaesthesia on circulating tumour cells after pancreatic adenocarcinoma resection: multicentre randomized clinical trial.
    Br J Surg. 2023 Nov 14:znad357. doi: 10.1093.
    PubMed    


    October 2023
  10. BOAG KF, Britton E, Knight SR, Coe PO, et al
    Definition and management of intra-abdominal metachronous oligometastatic pancreatic cancer: a systematic review.
    Br J Surg. 2023 Oct 31:znad338. doi: 10.1093.
    PubMed    


  11. UMANS DS, Timmerhuis HC, Anten MGF, Bhalla A, et al
    Prospective multicentre study of indications for surgery in patients with idiopathic acute pancreatitis following endoscopic ultrasonography (PICUS).
    Br J Surg. 2023 Oct 9:znad318. doi: 10.1093.
    PubMed     Abstract available


    July 2023
  12. DOPPENBERG D, van Dam JL, Han Y, Bonsing BA, et al
    Predictive value of baseline serum carbohydrate antigen 19-9 level on treatment effect of neoadjuvant chemoradiotherapy in patients with resectable and borderline resectable pancreatic cancer in two randomized trials.
    Br J Surg. 2023 Jul 13:znad210. doi: 10.1093.
    PubMed     Abstract available


    June 2023
  13. STRAND K, Moller JH
    Fluid treatment in acute pancreatitis: a careful balancing act.
    Br J Surg. 2023 Jun 16:znad155. doi: 10.1093.
    PubMed    


  14. MAGGINO L, Malleo G, Crippa S, Belfiori G, et al
    Pathological staging in postneoadjuvant pancreatectomy for pancreatic cancer: implications for adjuvant therapy.
    Br J Surg. 2023 Jun 1:znad146. doi: 10.1093.
    PubMed     Abstract available


  15. AMMER-HERRMENAU C, Lingens CHM, Ratei CS, Heuer C, et al
    Whole 16S rRNA sequencing of the oral microbiome predicts postoperative pancreatic fistula: prospective observational cohort study.
    Br J Surg. 2023 Jun 1:znad129. doi: 10.1093.
    PubMed    


    February 2023
  16. HUTTNER FJ, Mauch M, Heckler M, Hackert T, et al
    Influence of beta-blockers and other non-cancer drugs on outcomes after pancreatic cancer resection.
    Br J Surg. 2023 Feb 2:znac434. doi: 10.1093.
    PubMed    


    January 2023
  17. SHI X, Yin X, Gao S, Li B, et al
    Morphomolecular staging to improve stratification of patients with node-negative pancreatic cancer.
    Br J Surg. 2023 Jan 12:znac457. doi: 10.1093.
    PubMed    


  18. ZAHARIA C, Soreide K
    Call for better response evaluation after neoadjuvant therapy in pancreatic cancer.
    Br J Surg. 2023 Jan 12:znac452. doi: 10.1093.
    PubMed    


    December 2022

  19. Erratum to: Impact of classical and basal-like molecular subtypes on overall survival in resected pancreatic cancer in the SPACIOUS-2 multicentre study.
    Br J Surg. 2022 Dec 3:znac429. doi: 10.1093.
    PubMed    


  20. GOEL N, Rhim AD, Xi H, Olive KP, et al
    Transfusion of salvaged red blood cells during pancreatic ductal adenocarcinoma operations.
    Br J Surg. 2022 Dec 3:znac393. doi: 10.1093.
    PubMed    


    November 2022
  21. ISHII K, Yokoyama Y, Yonekawa Y, Hayashi D, et al
    Tranexamic acid and blood loss in pancreaticoduodenectomy: TAC-PD randomized clinical trial.
    Br J Surg. 2022 Nov 16. pii: 6828840. doi: 10.1093.
    PubMed     Abstract available


  22. YANG G, Qiu J, Xu J, Xiong G, et al
    Using a microRNA panel of circulating exosomes for diagnosis of pancreatic cancer: multicentre case-control study.
    Br J Surg. 2022 Nov 11. pii: 6821339. doi: 10.1093.
    PubMed    


  23. GIMBERG K, Enochsson L, Sandblom G
    Mortality and recurrence risk after a first episode of acute pancreatitis in the elderly: population-based study.
    Br J Surg. 2022 Nov 10. pii: 6819853. doi: 10.1093.
    PubMed    


  24. BROWN ZJ, Heh V, Labiner HE, Brock GN, et al
    Surgical resection rates after neoadjuvant therapy for localized pancreatic ductal adenocarcinoma: meta-analysis.
    Br J Surg. 2022 Nov 8. pii: 6811500. doi: 10.1093.
    PubMed     Abstract available


  25. JANSSEN BV, van Roessel S, van Dieren S, de Boer O, et al
    Histopathological tumour response scoring in resected pancreatic cancer following neoadjuvant therapy: international interobserver study (ISGPP-1).
    Br J Surg. 2022 Nov 4. pii: 6798894. doi: 10.1093.
    PubMed     Abstract available


  26. YUAN Y, Chen Y
    Comment on: Survival after active surveillance versus upfront surgery for incidental small pancreatic neuroendocrine tumours.
    Br J Surg. 2022 Nov 2. pii: 6794078. doi: 10.1093.
    PubMed    


    October 2022
  27. PECORELLI N, Palumbo D, Guarneri G, Gritti C, et al
    Preoperative CT image analysis to improve risk stratification for clinically relevant pancreatic fistula after distal pancreatectomy.
    Br J Surg. 2022 Oct 29. pii: 6779864. doi: 10.1093.
    PubMed    


  28. RICCI C, Partelli S, Landoni L, Bassi C, et al
    Author response to: Survival after active surveillance versus upfront surgery for incidental small pancreatic neuroendocrine tumours.
    Br J Surg. 2022 Oct 26. pii: 6774456. doi: 10.1093.
    PubMed    


  29. OBA A, Wu YHA, Schulick R, Del Chiaro M, et al
    Author response to: Comment on: Comparing neoadjuvant chemotherapy with or without radiation therapy for pancreatic ductal adenocarcinoma: National Cancer Database cohort analysis.
    Br J Surg. 2022 Oct 17. pii: 6761813. doi: 10.1093.
    PubMed    


  30. CHEN G, Chen Y
    Comment on: Comparing neoadjuvant chemotherapy with or without radiation therapy for pancreatic ductal adenocarcinoma: National Cancer Database cohort analysis.
    Br J Surg. 2022 Oct 3. pii: 6747090. doi: 10.1093.
    PubMed    


    August 2022
  31. PARTELLI S, Massironi S, Zerbi A, Niccoli P, et al
    Management of asymptomatic sporadic non-functioning pancreatic neuroendocrine neoplasms no larger than 2 cm: interim analysis of prospective ASPEN trial.
    Br J Surg. 2022 Aug 20. pii: 6672718. doi: 10.1093.
    PubMed    


  32. BONSDORFF A, Ghorbani P, Helantera I, Tarvainen T, et al
    Development and external validation of DISPAIR fistula risk score for clinically relevant postoperative pancreatic fistula risk after distal pancreatectomy.
    Br J Surg. 2022 Aug 19. pii: 6671587. doi: 10.1093.
    PubMed     Abstract available


  33. SUURMEIJER JA, Soer EC, Dings MPG, Kim Y, et al
    Impact of classical and basal-like molecular subtypes on overall survival in resected pancreatic cancer in the SPACIOUS-2 multicentre study.
    Br J Surg. 2022 Aug 18. pii: 6670906. doi: 10.1093.
    PubMed     Abstract available


  34. LIU X, Zhu M
    Comment on: Acute pancreatitis in pregnancy: meta-analysis of maternal and fetal outcomes.
    Br J Surg. 2022 Aug 18. pii: 6670911. doi: 10.1093.
    PubMed    


    July 2022
  35. VAN WIJK L, Bongers BC, Berkel AEM, Buis CI, et al
    Improved preoperative aerobic fitness following a home-based bimodal prehabilitation programme in high-risk patients scheduled for liver or pancreatic resection.
    Br J Surg. 2022 Jul 19. pii: 6646051. doi: 10.1093.
    PubMed    


  36. PERY R, Smoot RL, Thiels CA, Cleary SP, et al
    Hepatobiliary and pancreatic resection for cholangiocarcinoma in patients with primary sclerosing cholangitis.
    Br J Surg. 2022 Jul 15. pii: 6644759. doi: 10.1093.
    PubMed    


    June 2022
  37. HALLE-SMITH JM, Pande R, Hall L, Hodson J, et al
    Perioperative interventions to reduce pancreatic fistula following pancreatoduodenectomy: meta-analysis.
    Br J Surg. 2022 Jun 21. pii: 6612720. doi: 10.1093.
    PubMed     Abstract available


    May 2022
  38. KEMPENEERS MA, Boermeester MA
    Author response to: Short- and long-term outcomes of selective use of Frey or extended lateral pancreaticojejunostomy in chronic pancreatitis.
    Br J Surg. 2022 May 20. pii: 6589957. doi: 10.1093.
    PubMed    


  39. RICCI C, Partelli S, Landoni L, Rinzivillo M, et al
    Survival after active surveillance versus upfront surgery for incidental small pancreatic neuroendocrine tumours.
    Br J Surg. 2022 May 20. pii: 6589936. doi: 10.1093.
    PubMed     Abstract available


  40. JULIANOV A, Saroglu A
    Comment on: Short- and long-term outcomes of selective use of Frey or extended lateral pancreaticojejunostomy in chronic pancreatitis.
    Br J Surg. 2022 May 20. pii: 6589664. doi: 10.1093.
    PubMed    


  41. HEIDSMA CM, Nieveen van Dijkum EJ
    Author response to: Watchful waiting for small non-functional pancreatic neuroendocrine tumours: Nationwide prospective cohort study (PANDORA).
    Br J Surg. 2022 May 17. pii: 6587120. doi: 10.1093.
    PubMed    


  42. WANG X
    Comment on: Watchful waiting for small non-functional pancreatic neuroendocrine tumours: nationwide prospective cohort study (PANDORA).
    Br J Surg. 2022 May 17. pii: 6587118. doi: 10.1093.
    PubMed    


  43. NICKEL F, Lang F, Kowalewski KF, Haney CM, et al
    Pancreatic surgery with or without drainage: propensity score-matched study.
    Br J Surg. 2022 May 17. pii: 6586613. doi: 10.1093.
    PubMed     Abstract available


  44. DAMANAKIS AI, Toader J, Wahler I, Plum P, et al
    Influence of patient sex on outcomes after pancreatic surgery: multicentre study.
    Br J Surg. 2022 May 16. pii: 6586217. doi: 10.1093.
    PubMed     Abstract available


    April 2022
  45. WANG X, Wang Z, Ke N
    Comment on: Venous wedge and segment resection during pancreatoduodenectomy for pancreatic cancer: impact on short- and long-term outcomes in a nationwide cohort analysis.
    Br J Surg. 2022 Apr 13. pii: 6567930. doi: 10.1093.
    PubMed    


  46. GROEN JV, Michiels N, Mieog JSD
    Author response to: Venous wedge and segment resection during pancreatoduodenectomy for pancreatic cancer: impact on short- and long-term outcomes in a nationwide cohort analysis.
    Br J Surg. 2022 Apr 13. pii: 6567931. doi: 10.1093.
    PubMed    


    March 2022
  47. TAN Q, Ke N
    Comment on: Radiological tumour invasion of splenic artery or vein in patients with pancreatic body or tail adenocarcinoma and effect on recurrence and survival.
    Br J Surg. 2022 Mar 2. pii: 6540575. doi: 10.1093.
    PubMed    


    February 2022
  48. OBA A, Wu YHA, Colborn KL, Karam SD, et al
    Comparing neoadjuvant chemotherapy with or without radiation therapy for pancreatic ductal adenocarcinoma: National Cancer Database cohort analysis.
    Br J Surg. 2022 Feb 8. pii: 6524037. doi: 10.1093.
    PubMed     Abstract available


  49. KEMPENEERS MA, van Hemert AKE, van der Hoek M, Issa Y, et al
    Short- and long-term outcomes of selective use of Frey or extended lateral pancreaticojejunostomy in chronic pancreatitis.
    Br J Surg. 2022 Feb 4. pii: 6522949. doi: 10.1093.
    PubMed     Abstract available


    January 2022
  50. VUILLE-DIT-BILLE RN, Staerkle RF, Soll C, Troller R, et al
    Extended versus standard lymph node dissection for pancreatic head and periampullary adenocarcinoma: systematic review.
    Br J Surg. 2022 Jan 18. pii: 6511022. doi: 10.1093.
    PubMed    


    November 2021
  51. GROEN JV, Michiels N, van Roessel S, Besselink MG, et al
    Venous wedge and segment resection during pancreatoduodenectomy for pancreatic cancer: impact on short- and long-term outcomes in a nationwide cohort analysis.
    Br J Surg. 2021 Nov 17. pii: 6430361. doi: 10.1093.
    PubMed     Abstract available


  52. HUGHES DL
    Author response to: Acute pancreatitis in pregnancy: meta-analysis of maternal and foetal outcomes.
    Br J Surg. 2021 Nov 3. pii: 6420339. doi: 10.1093.
    PubMed    


  53. YANG DJ, Li M, Lu HM
    Comment on: Acute pancreatitis in pregnancy: meta-analysis of maternal and foetal outcomes.
    Br J Surg. 2021 Nov 3. pii: 6420337. doi: 10.1093.
    PubMed    


    October 2021
  54. KANG JS, Choi YJ, Byun Y, Han Y, et al
    Radiological tumour invasion of splenic artery or vein in patients with pancreatic body or tail adenocarcinoma and effect on recurrence and survival.
    Br J Surg. 2021 Oct 27. pii: 6412735. doi: 10.1093.
    PubMed     Abstract available


  55. ISSA Y, Boermeester MA
    Management of chronic pancreatitis: more pain than gain?
    Br J Surg. 2021 Oct 14. pii: 6396997. doi: 10.1093.
    PubMed    


  56. GROEN JV, Smits FJ, Koole D, Besselink MG, et al
    Completion pancreatectomy or a pancreas-preserving procedure during relaparotomy for pancreatic fistula after pancreatoduodenectomy: a multicentre cohort study and meta-analysis.
    Br J Surg. 2021 Oct 5. pii: 6381514. doi: 10.1093.
    PubMed     Abstract available


    September 2021
  57. BHOME R, Karavias D, Armstrong T, Hamady Z, et al
    Intraoperative radiotherapy for pancreatic cancer: implementation and initial experience.
    Br J Surg. 2021 Sep 29. pii: 6377876. doi: 10.1093.
    PubMed    


  58. PEDRAZZOLI S
    Comment on: Prevention, prediction, and mitigation of postoperative pancreatic fistula.
    Br J Surg. 2021 Sep 28. pii: 6377196. doi: 10.1093.
    PubMed    


  59. TSILIMIGRAS DI, Pawlik TM
    Pancreatic neuroendocrine tumours: conservative versus surgical management.
    Br J Surg. 2021 Sep 14. pii: 6370089. doi: 10.1093.
    PubMed    


    August 2021
  60. LEE W, Oh M, Kim JS, Park Y, et al
    Metabolic activity by FDG-PET/CT after neoadjuvant chemotherapy in borderline resectable and locally advanced pancreatic cancer and association with survival.
    Br J Surg. 2021 Aug 11. pii: 6347629. doi: 10.1093.
    PubMed     Abstract available


    July 2021
  61. PANDANABOYANA S
    Exploring Koch's postulate for SARS-CoV-2-induced acute pancreatitis: is it all about the ACE?
    Br J Surg. 2021 Jul 6. pii: 6316026. doi: 10.1093.
    PubMed    


    June 2021
  62. HUGHES DL, Hughes A, White PB, Silva MA, et al
    Acute pancreatitis in pregnancy: meta-analysis of maternal and fetal outcomes.
    Br J Surg. 2021 Jun 28. pii: 6310415. doi: 10.1093.
    PubMed    


  63. WENIGER M, Hank T, Qadan M, Ciprani D, et al
    Influence of Klebsiella pneumoniae and quinolone treatment on prognosis in patients with pancreatic cancer.
    Br J Surg. 2021;108:709-716.
    PubMed     Abstract available


  64. OBA A, Wu YHA, Lieu CH, Meguid C, et al
    Outcome of neoadjuvant treatment for pancreatic cancer in elderly patients: comparative, observational cohort study.
    Br J Surg. 2021 Jun 22. pii: 6307483. doi: 10.1093.
    PubMed     Abstract available


    May 2021
  65. SCHNEIDER M, Hackert T, Strobel O, Buchler MW, et al
    Technical advances in surgery for pancreatic cancer.
    Br J Surg. 2021 May 27. pii: 6287225. doi: 10.1093.
    PubMed     Abstract available


  66. LAYTON GR, Chung WY, Isherwood J, Fraser RE, et al
    Endoscopic retrograde cholangiopancreatography in the COVID era: considerations for hepatobiliary and pancreatic surgery units.
    Br J Surg. 2021 May 17. pii: 6277144. doi: 10.1093.
    PubMed    


  67. MARCHEGIANI G, Bassi C
    Prevention, prediction, and mitigation of postoperative pancreatic fistula.
    Br J Surg. 2021 May 4. pii: 6263467. doi: 10.1093.
    PubMed    


    April 2021
  68. KOSTI A, Rybinski B, Javanmard-Emamghissi H, Laing R, et al
    Protocol letter: multicentre prospective cohort study of the early management of acute pancreatitis in Great Britain and Ireland: PANC Study (Pancreatitis: A National Cohort Study).
    Br J Surg. 2021 Apr 12. pii: 6224208. doi: 10.1093.
    PubMed    


    March 2021
  69. HEIDSMA CM, Engelsman AF, van Dieren S, Stommel MWJ, et al
    Watchful waiting for small non-functional pancreatic neuroendocrine tumours: nationwide prospective cohort study (PANDORA).
    Br J Surg. 2021 Mar 30. pii: 6202974. doi: 10.1093.
    PubMed    


  70. LATENSTEIN AEJ, Mackay TM, van der Geest LGM, van Eijck CHJ, et al
    Effect of centralization and regionalization of pancreatic surgery on resection rates and survival.
    Br J Surg. 2021 Mar 19. pii: 6178575. doi: 10.1093.
    PubMed     Abstract available


  71. RICCI C, Partelli S, Landoni L, Rinzivillo M, et al
    Sporadic non-functioning pancreatic neuroendocrine tumours: multicentre analysis.
    Br J Surg. 2021 Mar 16. pii: 6173849. doi: 10.1093.
    PubMed     Abstract available


  72. VAN ROESSEL S, Janssen BV, Soer EC, Farina Sarasqueta A, et al
    Scoring of tumour response after neoadjuvant therapy in resected pancreatic cancer: systematic review.
    Br J Surg. 2021;108:119-127.
    PubMed     Abstract available


  73. BI F, Qian Y, Song L, Qu H, et al
    Genome sequencing of pancreatic cancer: differential expression by location.
    Br J Surg. 2021;108:e67-e68.
    PubMed    


  74. OBA A, Inoue Y, Ono Y, Ishizuka N, et al
    Staging laparoscopy for pancreatic cancer using intraoperative ultrasonography and fluorescence imaging: the SLING trial.
    Br J Surg. 2021;108:115-118.
    PubMed    


  75. RAU KM, Chang CS, Pei SN, Hsieh MC, et al
    Comment on: Phase I/II study of adding intraperitoneal paclitaxel in patients with pancreatic cancer and peritoneal metastasis.
    Br J Surg. 2021 Mar 12. pii: 6168654. doi: 10.1093.
    PubMed    


  76. YAMADA S, Fujii T, Satoi S
    Author's reply: Phase I/II study of adding intraperitoneal paclitaxel in patients with pancreatic cancer and peritoneal metastasis (Br J Surg 2020; 107: 1811-1817).
    Br J Surg. 2021 Mar 6. pii: 6161217. doi: 10.1093.
    PubMed    


    February 2021
  77. PAUSCH TM, Mitzscherling C, Aubert O, Liu X, et al
    Applying an intraoperative predictive indicator for postoperative pancreatic fistula: randomized preclinical trial.
    Br J Surg. 2021 Feb 20. pii: 6145318. doi: 10.1093.
    PubMed     Abstract available


  78. STEPHENS JR, Wong JLC, Broomhead R, Stumpfle R, et al
    Raised serum amylase in patients with COVID-19 may not be associated with pancreatitis.
    Br J Surg. 2021 Feb 4. pii: 6128540. doi: 10.1093.
    PubMed    


    January 2021
  79. YAMADA S, Fujii T, Satoi S
    Author response to: Comment on: Phase I/II study of adding intraperitoneal paclitaxel in patients with pancreatic cancer and peritoneal metastasis.
    Br J Surg. 2021;108:e56.
    PubMed    


  80. YADAV T, Kurdia K, Irrinki S
    Intraperitoneal paclitaxel for pancreatic cancer with peritoneal metastasis.
    Br J Surg. 2021;108:e55.
    PubMed    


  81. YU X
    Comment on: Acute pancreatitis in a COVID-19 patient.
    Br J Surg. 2021;108:e48.
    PubMed    


  82. HIPP J, Hussung S, Timme-Bronsert S, Boerries M, et al
    Perioperative cell-free mutant KRAS dynamics in patients with pancreatic cancer.
    Br J Surg. 2021 Jan 26. pii: 6120257. doi: 10.1093.
    PubMed    


  83. WENNERBLOM J, Ateeb Z, Jonsson C, Bjornsson B, et al
    Reinforced versus standard stapler transection on postoperative pancreatic fistula in distal pancreatectomy: multicentre randomized clinical trial.
    Br J Surg. 2021 Jan 20. pii: 6104783. doi: 10.1093.
    PubMed     Abstract available


    October 2020
  84. BALZANO G, Falconi M
    Author response to: Modelling centralization of pancreatic surgery: some additional considerations.
    Br J Surg. 2020 Oct 13. doi: 10.1002/bjs.12056.
    PubMed    


  85. GIANOTTI L
    Modelling centralization of pancreatic surgery: some additional considerations.
    Br J Surg. 2020 Oct 13. doi: 10.1002/bjs.12057.
    PubMed    


  86. BHORIWAL S, Kumar S, Mishra A, Kumar N, et al
    Comment on: Randomized clinical trial of pancreaticogastrostomy versus pancreaticojejunostomy on the rate and severity of pancreatic fistula after pancreaticoduodenectomy.
    Br J Surg. 2020 Oct 10. doi: 10.1002/bjs.12045.
    PubMed    


  87. SALVIA R, Marchegiani G
    Evolving management of pancreatic cystic neoplasms.
    Br J Surg. 2020;107:1393-1395.
    PubMed    


    September 2020
  88. WENIGER M, Hank T, Qadan M, Ciprani D, et al
    Influence of Klebsiella pneumoniae and quinolone treatment on prognosis in patients with pancreatic cancer.
    Br J Surg. 2020 Sep 30. doi: 10.1002/bjs.12003.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Pancreatitis is free of charge.